Business ❯ Healthcare ❯ Pharmaceuticals

Acquisitions

Johnson & Johnson Novo Nordisk Merck KGaA Sanofi-Dren Bio Agreement AstraZeneca Merck Eli Lilly and Verve Therapeutics Sanofi Alkermes US WorldMeds Pfizer Novartis-Avidity Acquisition Cipla Melinta Therapeutics Merck and Cidara Acquisition Organon-Dermavant Eris Lifesciences Ophthalmology

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

CorMedix Shares Jump After Q3 Beat as Company Lifts 2025 Outlook

Alkermes to Buy Avadel in Up to $2.1 Billion Deal With CVR Tied to Lumryz Expansion

Novo Nordisk to Acquire Akero for Up to $5.2 Billion to Expand in MASH

DoorDash Signs Multi-Year Deal to Use Serve Robotics’ Sidewalk Bots for Deliveries

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline